Successful management of unstable angina in a ravulizumab-treated patient with paroxysmal nocturnal hemoglobinuria

Takahashi, H; Mori, H; Fukatsu, M; Sano, T; Harada, K; Oikawa, M; Takeishi, Y; Kimura, S; Ohkawara, H; Shichishima, T; Ikezoe, T

Ikezoe, T (通讯作者),Fukushima Med Univ, Dept Hematol, Fukushima, Japan.

FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2022; 68 (3): 175

Abstract

Ravulizumab is an anti-C5 antibody approved for treating paroxysmal nocturnal hemoglobinuria (PNH). In August 2019, a 77-year-old Japanese man with PN......

Full Text Link